In-vivo and in-silico studies revealed the molecular mechanisms of Colocasia esculenta phenolics as novel chemotherapy against benign prostatic hyperplasia via inhibition of 5α-reductase and α1-adrenoceptor.

Deusdedit TusubiraJonasi MunezeroPeter Chinedu AguClement Olusoji AjayiJoseph OloroNathiim NamaleFrank SsedyabaneCaroline Kiwanuka NakiguliAbayomi E AdegboyegaPatrick Maduabuchi Aja

Published in: In silico pharmacology (2023)

Keyphrases

benign prostatic hyperplasia
lower urinary tract symptoms
molecular docking
locally advanced
case control
single cell
squamous cell carcinoma
radiation therapy